Schedule 13G ownership disclosure

Nabriva Therapeutics AG

Security class unavailable · CUSIP: 62957M104

Event date: 2015-09-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
275,988
Percent of class
13.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-069102
Form type
SC 13G
Filer
HBM Healthcare Investments (Cayman) Ltd.
CIK
CIK 1232258
Filed
Oct 05, 2015
Reporting period
Sep 23, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub